XNAS · Healthcare · Biotechnology
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | Q3 2026 | 0.52 | 0.53 | +1.92% | $311.4M | ✅ Beat | +0.00% | -5.31% | — |
| 2026-02-04 | Q2 2026 | 0.40 | 0.46 | +15.00% | $295.9M | ✅ Beat | +5.18% | -7.60% | -21.52% |
| 2025-11-05 |
| Q1 2026 |
| 0.40 |
| 0.42 |
| +5.00% |
| $286.6M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-06 | Q4 2025 | 0.48 | 0.53 | +10.42% | $317.0M | ✅ Beat | +0.48% | +9.71% | +9.10% |
| 2025-02-05 | Q2 2025 | 0.38 | 0.42 | +10.53% | $297.0M | ✅ Beat | -0.32% | -10.38% | -14.46% |
| 2024-10-30 | Q1 2025 | 0.38 | 0.42 | +10.53% | $289.5M | ✅ Beat | -2.99% | -0.25% | -0.87% |
| 2024-08-07 | Q4 2024 | 0.49 | 0.49 | +0.00% | $306.1M | ➖ Inline | +3.40% | +2.52% | +0.75% |
| 2024-05-01 | Q3 2024 | 0.45 | 0.48 | +6.67% | $303.4M | ✅ Beat | +2.91% | +4.89% | +5.08% |
Showing last 8 quarters.